Forskningsprosjekter

  • The FARP study: a randomized controlled trial comparing focal prostate ablation (focal HIFU) to radical prostatectomy has now completed its follow-up phase, and the results are eagerly awaited.
  • The prePSMA study (PhD project Lars Qvigstad): Preoperativ PSMA PET/CT as triage for RALP patients scheduled for ePLND.
  • PeP-RALP (PhD project Shivanthe Sivanesan): The impact of beta-adrenerg signalling in recurrence and metastasis in prostate cancer. This feasibility study has finished recruiting last year.
  • Short- and long-term oncological and functional outcomes after radical prostatectomy (PhD project Daniyal Noor)
  • SPCG-17. Prostate Cancer Active Surveillance Trigger Trial.
  • NORAPP studien (PhD project Maciej Jacewicz): Norwegian randomized study on antibiotic propylaxis in transperineal prostate biopsy
  • The Oslo model: Development and evaluation of a lymph node invasion prediction model
  • SPCG-19: A randomized, controlled, open-label, prospective, multicenter intervention trial of immediate curative therapy versus conservative treatment in older patients with non-metastatic, high-risk prostate cancer
  • The homeobox transcription factor PBX – a putative prognostic marker and drug target of prostate cancer
    Prosjektleder: Kristin Austlid Taskén
  • Development of hormone refractory prostate cancer: Role of β2-adrenergic receptor
    Prosjektleder: Kristin Austlid Taskén
  • The Norwegian Prostate Cancer Biomarker Consortium
    Prosjektleder: Kristin Austlid Taskén
  • Movember GAP1 Serum Biomarker Project
    Prosjektleder: Kristin Austlid Taskén
  • Salvage brachyterapi
    Prosjektleder: Wolfgang Lilleby
  • Metastatisk prostata cancer: UV1 synthetic peptide vaccine and GM-CSF
    Prosjektleder: Wolfgang Lilleby
  • SPCG-15: Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
    Prosjektleder: Wolfgang Lilleby og Bjørn Brennhovd
  • Movember GAP1 Unique TMA Project
    Prosjektleder: Viktor Berge
  • Laparoscopic radical prostatectomy and  robot assisted radical prostatectomy: Outcome and adverse effects
    Prosjektleder: Viktor Berge
  • SPCG 12: Adjuvant Taxoter etter radikal prostatektomi
    Prosjekleder: Jon Roar Hoff
  • SPCG 13: Adjuvant Taxotere etter strålebehandling
    Prosjektleder: Jon Reidar Iversen
  • Påvirker MR prostata kirurgisk gjennomføring og resultat
    Prosjektleder: Erik Rud
  • Staging and characterization of primary prostate cancer using mpMRI and PET
    Prosjektleder: Knut Håkon Hole
  • Salvage HIFU
    Prosjektleder: Eduard Baco
  • Primary hemi HIFU
    Prosjektleder: Eduard Baco
  • Curative intended treatment for prostate cancer. adverse effectsInternational comparison
    Prosjektleder: Sophie D Fosså
  • Curative Treatment of Prostate Cancer and Workforce Participation
    Prosjektleder: Sophie D Fosså
  • Adverse effects after curative treatment of Prostate cancer  International Comparison         
    Prosjektleder: Sophie D Fosså          
  • MR før målrettet prostata biopsi: Koelis studiePost-prostatectomy urinary  incontinence
    Prosjektleder: Alv A Dahl
  • Microvesicles and Prostate Cancer: Looking for Biomarkers and Release Mechanisms
    Prosjektleder: Alicia Llorente
  • MR guided HIFU of the Prostate
    Prosjektleder: Per Kristian Hol
  • Genome-based prostate cancer
    Prosjektleder: Rolf Skotheim
  • PET/CT av prostata cancer med FACBC isotop
    Prosjektleder: Tore Bach-Gansmo
  • University of Southern California, Los Angeles USA Gill I.S:.& Ukimura O.: Characterisaton of Index tumor of prostatae using  MRi and Targeted biopsy in correlation with step sectioned RP specimen
    Prosjektleder: Eduard Baco
  • Pattern of Care   of prostate cancer I Norway
    Prosjektleder: Sophie D. Fosså
  • Radiotherapy after Prostatectomy (RP) for Prostate Cancer: Quality of Life and long-term Adverse Effects
    Prosjektleder: Andreas Stensvold, Sophie D. Fosså, Rune Kvåle
  • The testing of a signature of a metastatic subgroup of prostate cancers in an independent cohort of samples
    Prosjektleder: Viktor Berge
  • Role of Serum Response Factor (SRF) in biochemical recurrence in prostate cancer
    Prosjektleder: Kristin Tasken
  • Evaluering av protein biomarkører for prostatakreft i blodprøver
    Prosjektleder: Ian Mills/Ingrid J. Guldvik
Publisert 19. feb. 2013 13:49 - Sist endret 10. nov. 2025 14:09
Del på e-post